What is an appropriate treatment plan for epistaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Plan for Epistaxis (R04.0)

Begin immediate treatment with firm external nasal pressure for 10-15 minutes while the patient sits upright and leans forward, followed by topical vasoconstrictor application (oxymetazoline) if bleeding persists, then proceed to cautery or nasal packing based on bleeding site identification. 1

Initial Assessment and Risk Stratification

Document critical risk factors immediately: 1

  • Personal or family history of bleeding disorders 1
  • Anticoagulant or antiplatelet medication use (aspirin, clopidogrel, warfarin) 1, 2
  • Intranasal drug use 1
  • Prior nasal/sinus surgery or facial trauma 1
  • Chronic kidney or liver disease 1
  • CPAP or nasal cannula oxygen use 1

Identify bleeding location: 1

  • Anterior epistaxis (95% of cases) - typically Kiesselbach's plexus 3
  • Posterior epistaxis (5% of cases) - requires more aggressive intervention 3
  • Consider nasal endoscopy for recurrent, severe, or difficult-to-control bleeding (localizes bleeding site in 87-93% of cases) 1

Stepwise Treatment Algorithm

Step 1: First-Line Interventions (Controls 65-75% of Cases)

Apply external pressure: 1, 3

  • Pinch soft area of nose firmly for 10-15 minutes 1
  • Patient sits upright, leans forward to prevent blood swallowing 4

Topical vasoconstrictors (if pressure fails): 1

  • Oxymetazoline 0.05% spray or on cotton pledget 1, 4
  • Alternative: phenylephrine 1
  • Stops bleeding in 65-75% of emergency department cases 1, 5
  • Caution: May increase cardiac complications in susceptible patients 1

Step 2: Definitive Treatment for Identified Bleeding Site

For anterior bleeding with visible source: 1

Cauterization (preferred for localized bleeding): 1, 5

  • Chemical cautery: Silver nitrate application after topical anesthesia 1, 4
  • Electrocautery: More effective than chemical with fewer recurrences (14.5% vs 35.1%) 5
  • Apply to decongested and anesthetized mucosa 4
  • Avoid bilateral septal cautery to prevent perforation 1

Topical tranexamic acid (especially for antiplatelet users): 2

  • Mean bleeding cessation time: 6.7 minutes vs 11.5 minutes with phenylephrine-lidocaine packing 2
  • Reduces rebleeding: 6% vs 20% with traditional packing 2
  • Particularly effective in patients on aspirin or clopidogrel 2
  • Promotes hemostasis in 78% of patients vs 35% with oxymetazoline 5

Step 3: Nasal Packing (If Above Measures Fail)

Anterior packing options: 5, 4

  • Inflatable anterior nasal balloon packs (Rapid-Rhino) - reliably control most nosebleeds 4
  • PVA nasal tampons (Merocel) 5
  • Absorbable materials: Nasopore nasal tampon 5
  • Newer hemostatic materials (more effective, fewer complications): 5
    • Hemostatic gauzes (Surgicel) 5
    • Thrombin matrix (Floseal) 5
    • Gelatin sponge (Spongostan) 5
    • Fibrin glue 5

Posterior packing (for posterior epistaxis): 4

  • Foley catheter nasopharyngeal balloon pack 4
  • Applied after anterior packing if bleeding continues 4

Packing management: 1

  • Consider prophylactic antibiotics if infection risk is high 1
  • Keep packing moist with nasal saline sprays 1
  • Strict follow-up for nonresorbable packing removal 1
  • Monitor for complications: infection, septal perforation, pressure necrosis 1

Step 4: Advanced Interventions (Refractory Cases)

Endoscopic surgical management: 5, 6

  • Endoscopic sphenopalatine artery (SPA) ligation: 97% success vs 62% with packing alone 5, 6
  • Endoscopic cauterization: More effective than ligation 5
  • Consider early surgery over prolonged packing for posterior epistaxis 6

Interventional radiology: 5, 7

  • Percutaneous embolization using gelatin sponge, foam, PVA, or coils 5
  • 80% success rate 5
  • Alternative for high-risk surgical candidates 7
  • Typically reserved after surgical failure, except in specific high-risk patients 6

Post-Treatment Management

Activity restrictions: 1

  • Avoid straining, lifting >10 pounds, bending over, exercising 1
  • Sleep with head elevated 1
  • No nose blowing with packing in place 1
  • Sneeze with mouth open 1

Pain management: 1

  • Acetaminophen (Tylenol) - does not increase bleeding 1
  • Avoid aspirin and ibuprofen - increase bleeding risk 1

Nasal care: 1

  • Nasal saline spray throughout day 1
  • Moisturizing/lubricating agents after bleeding stops 1
  • Humidifier use 1

Discharge instructions with oxymetazoline 0.05% spray for rebleeding management 4

Warning Signs Requiring Immediate Re-evaluation

Instruct patients to return for: 1

  • Return of blood from nose or mouth 1
  • Fever >101°F 1
  • Increasing pain 1
  • Vision changes 1
  • Shortness of breath or labored breathing 1
  • Loss of color around nasal skin 1
  • Facial swelling 1
  • Diffuse skin rash 1

Special Considerations

For patients on anticoagulation/antiplatelet therapy: 2

  • Topical tranexamic acid is particularly effective 2
  • Do not routinely discontinue anticoagulation without consulting prescribing physician 1

Recurrent epistaxis: 1

  • Consider nasal endoscopy to exclude foreign body, tumor, or vascular malformation 1
  • Evaluate for hereditary hemorrhagic telangiectasia (HHT) if family history present 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Simplified management of epistaxis.

Journal of the American Association of Nurse Practitioners, 2021

Research

Epistaxis Treatment Options: Literature Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Research

Posterior epistaxis management: review of the literature and proposed guidelines of the hellenic rhinological-facial plastic surgery society.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.